14 episodios
Hematopoiesis: An ASH Trainee Council Production American Society of Hematology
-
- Ciencias
The American Society of Hematology Trainee Council is proud to announce the creation of a new podcast to accompany our new trainee-focused publication Hematopoiesis. The podcast is by and for hematology trainees at all levels of training, from medical students to residents to fellows to doctoral students, and all episodes are created and produced by the ASH Trainee Council. With Hematopoiesis and our new podcast, we aim to bring content about the history of hematology, career pathways in hematology, and the latest clinical and research updates to trainees worldwide.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebo…ew-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
-
Celebrating Pride Month with Career Development Advice for LGBTQ+ Hematology Trainees
In this Pride Month-themed episode of Hematopoiesis, Drs. Emily Liang, Ajay Major, Michael Hochman, and Shail Maingi discuss career development, community building, and navigating the workforce for LGBTQ+ trainees in hematology.
-
Caring for Older Adults with Blood Disorders: An Introduction to Geriatric Hematology
Tune in to the Hematopoiesis podcast to hear a conversation about the increasingly relevant topic of geriatric hematology. Many blood disorders and hematologic malignancies are diseases of older adults, and in this introduction to geriatric hematology, Drs. Maya Abdallah and Ajay Major talk about “staging the aging.”
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/. -
Choosing Your Target as a Physician Scientist
Join Physician Scientist and Nobel Laureate Dr. Bill Kaelin and Dr. Eric Vick of the ASH Trainee Council to discuss choosing your target as a physician scientist, discussing your choice of target in your career and in your scientific exploration.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/. -
Tips for Trainees for a Career in Publishing with Drs. Nancy Berliner and Andrew Roberts
In this episode, Trainee Council Chairs, Drs. Becky Zon and Ajay Major, interview Dr. Nancy Berliner, Blood Editor-in Chief and Dr. Andrew Roberts, Blood Deputy Editor, on their careers in academic editing and publishing, including career development tips for trainees who are interested in a career in publishing.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/. -
Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies
In the second episode of this Hematopoiesis Bench to Bedside series, Dr. Manuel Espinoza-Gutarra has conversations with Dr. Aaron Mitchell, Dr. Yousuf Zafar (@yzafar), Dr. Aju Mathew, and Dr. Nandita Khera (@khera_nandita), experts in the field of financial toxicity in cancer patients, who offer different perspectives regarding the impact of the financial costs of modern anticancer treatment puts on patients, how should we adequately measure it and how to tackle it.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/. -
The Era of Gene Therapy in Clinical Hematology, From Bench to Bedside!
In this episode of Hematopoiesis, Dr. Alexis Caulier has exciting conversations with three experts in the field about how early bench work on the genetic regulation of fetal hemoglobin led to the development of bedside gene therapies. Dr. David Nathan revisits the beneficial role of fetal hemoglobin to improve the clinical manifestations of hemoglobinopathies. Dr. Vijay Sankaran (@bloodgenes) highlights the great impact of studying gene regulatory networks in developing innovative gene therapies, and Dr. Courtney Fitzhugh (@CourtneyFitzhu1) emphasizes the importance and the specificities of clinical trials for innovative therapies.